Chromadex Corp reports results for the quarter ended in September 30 - Earnings Summary

Niagen Bioscience

01/11/2024 03:10

* Chromadex Corp  CDXC.OQ  reported quarterly adjusted
earnings of
2 cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -1 cents.  The mean expectation of four analysts for the
quarter was for breakeven results per share. Wall Street
expected results to range from zero cents to 1 cents per share.
    * Revenue rose 31.2% to $25.58 million from a year ago;
analysts
expected $23.64 million. 
    * Chromadex Corp's reported EPS for the quarter was 2
cents​.
    * The company reported quarterly net income of $1.88
million.
    * Chromadex Corp shares had fallen by 1.9% this quarter and
gained 150.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 50.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Chromadex Corp is
6.35 
This summary was machine generated from LSEG data November 1 at
03:09 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.00           0.02           Beat
 Jun. 30 2024      -0.02          0.00           Beat
 Mar. 31 2024      -0.02          -0.01          Beat
 Dec. 31 2023      -0.03          0.00           Beat